Published in Z Kardiol on February 01, 2005
Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol (1990) 2.07
Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation (1999) 1.18
Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther (1990) 1.12
Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardiovasc Pharmacol (1987) 1.05
Caffeine and hypertension. Am J Med (1984) 0.96
Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med (1995) 0.96
Circulatory effects of coffee in relation to the pharmacokinetics of caffeine. Am J Cardiol (1985) 0.90
[Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET]. Z Kardiol (2003) 0.89
[Improved coronary vasodilator capacity by drug lipid lowering therapy in patients in the early stage of coronary atherosclerosis with reduced coronary reserves and moderate LDL hypercholesteremia]. Z Kardiol (1998) 0.84
A randomized comparison of 4 doses of intracoronary adenosine in the assessment of fractional flow reserve. Z Kardiol (2003) 0.84
TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res (2003) 29.26
TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res (2006) 22.20
The TRANSFAC system on gene expression regulation. Nucleic Acids Res (2001) 13.63
Combined spatial and temporal imaging of brain activity during visual selective attention in humans. Nature (1994) 2.89
[1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med (2001) 1.78
[Prospective study of the incidence, pathogenesis and therapy of spontaneous, by coronary angiography diagnosed coronary artery dissection]. Z Kardiol (1998) 1.77
Neural mechanisms of global and local processing. A combined PET and ERP study. J Cogn Neurosci (1998) 1.76
The importance of secondary mitral valve involvement in primary aortic valve endocarditis; the mitral kissing vegetation. Eur Heart J (2002) 1.61
Increased risk of bacterial endocarditis in inflammatory bowel disease. Am J Med (1992) 1.47
[Recurrent immune thrombocytopenia: a rare complication after contrast medium injection]. Dtsch Med Wochenschr (1995) 1.46
[Acute mitral insufficiency in osteogenesis imperfecta]. Dtsch Med Wochenschr (1994) 1.41
Prosthetic valve endocarditis. Heart (2001) 1.40
Limitations of clearance determination using the single sample distribution volume method. An error analysis on the basis of compartment models. Eur J Nucl Med (1992) 1.39
[Repeated ingestion with suicidal intent of potentially lethal amounts of thallium]. Dtsch Med Wochenschr (1995) 1.39
[The local lysis therapy of spontaneous renal artery dissection with arterial thrombosis]. Dtsch Med Wochenschr (1992) 1.38
[Prevention of endocarditis 1998--what is reliable?]. Dtsch Med Wochenschr (1998) 1.38
One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response. Clin Res Cardiol (2007) 1.35
Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (1995) 1.21
The Björk-Shiley 70 degree convexo-concave prosthesis strut fracture problem (present state of information). Thorac Cardiovasc Surg (1987) 1.19
Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus. J Neurol (1997) 1.13
[Epidural spinal cord stimulation for therapy of chronic pain. Summary of the S3 guidelines]. Schmerz (2011) 1.08
Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med (1999) 1.06
Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. Appl Radiat Isot (2003) 1.06
Antibiotic prophylaxis for infective endocarditis from an international group of experts towards a European consensus. Group of Experts of the International Society for Chemotherapy. Eur Heart J (1995) 1.03
Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis (2001) 1.02
Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest (1993) 1.00
Adaptive servoventilation in diastolic heart failure and Cheyne-Stokes respiration. Eur Respir J (2009) 0.99
Two-dimensional strain analysis of the global and regional myocardial function for the differentiation of pathologic and physiologic left ventricular hypertrophy: a study in athletes and in patients with hypertrophic cardiomyopathy. Int J Cardiovasc Imaging (2010) 0.96
Accurate local blood flow measurements with dynamic PET: fast determination of input function delay and dispersion by multilinear minimization. J Nucl Med (1993) 0.96
Better understanding of the pathogenesis of prosthetic valve endocarditis--recent perspectives for prevention strategies. J Heart Valve Dis (1998) 0.95
A kinetic model for cardiac PET with [1-carbon-11]-acetate. J Nucl Med (1996) 0.95
[Not Available]. Z Kardiol (2002) 0.93
Multimodality in imaging calcific constrictive pericarditis. Heart (2006) 0.93
[Aortic stenosis]. Clin Res Cardiol (2006) 0.92
[Prevalence of sleep-related breathing disorders in ischemic and non-ischemic heart failure]. Dtsch Med Wochenschr (2007) 0.92
[Analysis of inter- and intraventricular asynchrony by tissue Doppler echocardiography]. Z Kardiol (2003) 0.91
Steroid resistant nephrotic syndrome associated with spondyloepiphyseal dysplasia, transient ischemic attacks and lymphopenia. Clin Nephrol (1995) 0.91
Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake. Cor Vasa (1985) 0.91
Evaluation of the incorporation of bone grafts used in maxillofacial surgery with [18F]fluoride ion and dynamic positron emission tomography. Eur J Nucl Med (1995) 0.90
[Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET]. Z Kardiol (2003) 0.89
Late complications in patients with Björk-Shiley and St. Jude Medical heart valve replacement. Circulation (1983) 0.89
Assessment of myocardial viability by use of 11C-acetate and positron emission tomography. Threshold criteria of reversible dysfunction. Circulation (1997) 0.89
Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. Z Kardiol (2005) 0.88
Death due to transprosthetic catheterization of a Björk-Shiley prosthesis in the aortic position. Am J Cardiol (1986) 0.88
[Myocardial perfusion scintigraphy 2012 in Germany. Results of the 6th Query]. Nuklearmedizin (2013) 0.88
Prosthetic valve endocarditis: clinical findings and management. Eur Heart J (1984) 0.87
Diagnostic superiority of a combined assessment of the systolic and early diastolic mitral annular velocities by tissue Doppler imaging for the differentiation of restrictive cardiomyopathy from constrictive pericarditis. Clin Res Cardiol (2010) 0.86
A randomised, non-crossover study of the GuardianCPV Laryngeal Mask versus the LMA Supreme in paralysed, anaesthetised female patients. Anaesthesia (2013) 0.86
[An increased incidence of bacterial endocarditis in chronic inflammatory bowel diseases]. Z Gastroenterol (1992) 0.86
Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors. Urol Int (2002) 0.85
Echo-guided percutaneous coil embolization of a symptomatic massive metastasis of a renal cell carcinoma in the right ventricular outflow tract. Eur J Echocardiogr (2008) 0.85
[Myocardial perfusion scintigraphy 2007 in Germany--results of the query and current status]. Nuklearmedizin (2009) 0.85
Electrocardiographic remodeling in patients paced for heart failure. Am J Cardiol (2000) 0.85
[Myocardial perfusion scintigraphy 2008 in Germany - results of the fourth query]. Nuklearmedizin (2010) 0.84
Synthesis and evaluation of fluorine-18 labelled compounds for imaging of bacterial infections with pet. Appl Radiat Isot (2006) 0.84
Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest (1998) 0.84
[Myocardial perfusion scintigraphy 2006 in Germany. Results of the query and current status]. Nuklearmedizin (2008) 0.83
[Acute myocardial infarct caused by a muscle bridge of the anterior interventricular ramus: complicated course with vascular perforation after stent implantation]. Z Kardiol (1997) 0.83
[Myocardial perfusion scintigraphy in Germany. Results of the 2005 query and current status]. Nuklearmedizin (2007) 0.83
The effect of beta blocker withdrawal on adenosine myocardial perfusion imaging. J Nucl Cardiol (2014) 0.81
[Validation of continuous blood pressure measurements by pulse transit time: a comparison with invasive measurements in a cardiac intensive care unit]. Dtsch Med Wochenschr (2010) 0.81
Improvement of brain SPECT by stabilization of Tc-99m-HMPAO with methylene blue or cobalt chloride. Comparison with Tc-99m-ECD. Nuklearmedizin (1999) 0.81
Cardiorespiratory screening for sleep-disordered breathing. Eur Respir J (2006) 0.81
Dose-related effect of intravenous L-arginine on muscular blood flow of the calf in patients with peripheral vascular disease: a H215O positron emission tomography study. Clin Sci (Lond) (1997) 0.81
Atrial fibrillation in carcinoid heart disease: The role of serotonin. A review of the literature. Clin Res Cardiol (2006) 0.80
Five-year results after randomized mitral valve replacement with Björk-Shiley. Lillehei-Kaster, and Starr-Edwards prostheses. Thorac Cardiovasc Surg (1983) 0.80
Right atrial hemangioma in modern cardiac imaging. Clin Res Cardiol (2006) 0.80
Radiation protection during cardiac catherization: development of an improved lead apron for periinterventional echocardiography. Minerva Cardioangiol (2015) 0.80
Reoperations for malfunction of heart valve prostheses, especially with endocarditis. Thorac Cardiovasc Surg (1987) 0.79
[Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy]. Z Kardiol (2003) 0.79
Intra-individual head-to-head comparison of Sirolimus®- and Paclitaxel®-eluting stents for coronary revascularization. A randomized, multi-center trial. Int J Cardiol (2012) 0.79
[Benefits of endocarditis prevention in patients with prosthetic heart valves]. Z Kardiol (1986) 0.79
Lipid apheresis: oxidative stress, rheology, and vasodilatation. Clin Res Cardiol Suppl (2012) 0.79
3-O-methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging. Eur J Nucl Med Mol Imaging (2003) 0.79
Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012. Eur J Nucl Med Mol Imaging (2014) 0.79
[18F]fluoride PET indicates reduced bone formation in severe glucocorticoid-induced osteoporosis. Nuklearmedizin (1998) 0.79
[Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology]. Z Kardiol (1995) 0.79
[S2 guideline for infectious endocarditis]. MMW Fortschr Med (2004) 0.79
Hypertrophic cardiomyopathy in cardiac CT: a validation study on the detection of intramyocardial fibrosis in consecutive patients. Int J Cardiovasc Imaging (2014) 0.78
[H.E.L.P. apheresis and oxidative stress]. Z Kardiol (2003) 0.78
Determination of anatomical skeletal muscle mass by whole body nuclear magnetic resonance. Basic Life Sci (1993) 0.78
Potential flaws in the assessment of minor cerebrovascular events after heart valve replacement. J Heart Valve Dis (1993) 0.78
[Myocardial perfusion scintigraphy - short form of the German guideline]. Nuklearmedizin (2013) 0.78
Persistent vegetative state: evaluation of brain metabolism and brain perfusion with PET and SPECT. Nucl Med Commun (2003) 0.78
Is myocardial Na+/Ca2+ exchanger transcription a marker for different stages of myocardial dysfunction? Quantitative polymerase chain reaction of the messenger RNA in endomyocardial biopsies of patients with heart failure. J Am Coll Cardiol (2000) 0.78
A compartmental model for alveolar clearance of pertechnegas. J Nucl Med (1996) 0.78
[Optimal management of primary and secondary mitral regurgitation]. Herz (1998) 0.77
[Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy ]. Dtsch Med Wochenschr (2008) 0.77
Patch-graft enlargement of the aortic root using autologous pericardium (long-term results). Thorac Cardiovasc Surg (1983) 0.77
[Non-surgical management of a perforated left anterior descending coronary artery following cardiopulmonary resuscitation]. Z Kardiol (1999) 0.77
Left ventricular mass and oxygen uptake in top handball athletes. Int J Sports Med (2012) 0.77
[Detection and therapy of respiratory dysfunction by implantable (cardiac) devices]. Herz (2014) 0.77